Market ExpansionFemaSeed is now being offered in more than 60 clinics across the U.S., which could allow for quick patient access.
Regulatory ApprovalsFemBloc received EU approval, and the company announced partnerships in Spain, indicating international market expansion.
Strategic PartnershipsNew partnership with CNY Fertility expands commercial footprint for FemaSeed, increasing revenue potential.